Showing results (341-350 of 439) with videos related to

Sort By:
Pageof 44
European Urology Oncology|November 9, 2024
Correlation of Body Mass Index with Overall Survival Among Patients with Metastatic Hormone-sensitive Prostate Cancer: Analysis of Patient-level Data from SWOG-1216Umang Swami, Yeonjung Jo, Arshit Narang, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 29, 2024
Early antiplatelet therapy after intravenous thrombolysis for acute ischemic stroke: a systematic review and meta-analysisHesham Kelani, Ahmed Naeem, Rowan H Elhalag, et al.
BJU International|May 6, 2008
Adjuvant chemotherapy for bladder cancer does not alter cancer-specific survival after cystectomy in a matched case-control studyJochen Walz, Shahrokh F Shariat, Nazareno Suardi, et al.
World Journal of Urology|September 9, 2016
Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)Francesco Soria, Shahrokh F Shariat, Seth P Lerner, et al.
Journal of Neuroscience Research|July 9, 2019
Phenotype onset in Huntington's disease knock-in mice is correlated with the incomplete splicing of the mutant huntingtin geneNicholas R Franich, Miriam A Hickey, Chunni Zhu, et al.
The Journal of Urology|November 17, 2009
Combination of multiple molecular markers can improve prognostication in patients with locally advanced and lymph node positive bladder cancerShahrokh F Shariat, Daher C Chade, Pierre I Karakiewicz, et al.
The Journal of Urology|May 1, 2017
Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO GuidelineSam S Chang, Bernard H Bochner, Roger Chou, et al.
Development (Cambridge, England)|June 25, 2005
Abnormalities in cartilage and bone development in the Apert syndrome FGFR2(+/S252W) mouseYingli Wang, Ran Xiao, Fan Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 11, 2022
Considerations on Integrating Prostate-Specific Membrane Antigen Positron Emission Tomography Imaging Into Clinical Prostate Cancer Trials by National Clinical Trials Network Cooperative GroupsHeiko Schöder, Thomas A Hope, Michael Knopp, et al.
Future Oncology (London, England)|May 24, 2022
Targeting <i>FGFR3</i> alterations with adjuvant infigratinib in invasive urothelial carcinoma: the phase III PROOF 302 trialSumanta K Pal, Diederik M Somford, Petros Grivas, et al.
Pageof 44